InClinica CEO Speaks at the National Conference for Clinical Research in Israel
James Nolan discussed the global clinical trial crisis in Tel Aviv
PHILADELPHIA (February 5, 2018) – InClinica, a global, clinical CRO, announced that CEO James Nolan spoke at the National Conference for Clinical Research in Israel on February 5 in Tel Aviv, Israel.
Nolan’s lecture, titled “The Global Clinical Trial Crisis,” addressed some of the key issues hindering the success of clinical trials. He also offered guidance on how CROs can compete in this continuously changing landscape.
“The number of clinical trials continues to grow globally, but that doesn’t mean they’re all succeeding,” said Nolan. “There are a number of key issues facing clinical trials, from IRBs to recruitment issues, and only the CROs that are able to adapt to these needs will be able to succeed for their clients.”
The National Conference for Clinical Research in Israel presents updates in various areas of the clinical research industry. Topics include regulation, global trends, database management, and developments in the field in both Israel and globally. For more information, visit: http://www.medical-expo.co.il/clinical-trials-2018-information.aspx.
InClinica is a global clinical contract research organization founded in 2016 after the acquisition of an existing global CRO. With a senior management team that brings more than 100 combined years of experience, InClinica works across all phases of the clinical research process and has a particular strength in first in man and phase 2 studies. InClinica is headquartered in Philadelphia with other locations in Israel, Malaysia/Singapore., the U.K., and throughout Europe.